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The usual management of upper aero digestive tract 
squamous cell carcinoma is surgery associated or not to 
post surgical radiotherapy. Loco-regional relapses constitute 
the main failure of the initial treatment and early diagnosis 
justifies the indication of salvage surgery. Aim: Descriptive 
analysis of demographic data and staging for salvage surgery 
of oropharynx tumors. Material and methods: We studied 
retrospectively 78 patients submitted to surgery in all cases; 
however, just 37 patients received post surgical radiotherapy. 
Results: There was a predominance of males in 70 cases, 
with mean age of 54.2 years, and 54 patients were Caucasian. 
The patients were classified as T3 and T4 in 38 cases and 40 
patients were classified as N0 neck. 35 patients developed 
loco-regional distant relapses. 17 patients were submitted 
to salvage surgery and 12 patients were reclassified as T1; 2 
patients T2 and in relation to the clinical stage N, 2 patients 
were N2a and 2 patients N2b. The average age of the 
patients submitted to salvage surgery was 52.8 years, with 
predominance of male Caucasians. Conclusion: Clinical 
stage I and II were accorded salvage surgery.
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INTRODUCTION
Surgery, with or with no postoperative radiotherapy, 
is the classical treatment of epidermoid carcinomas of the 
head and neck.1 Head and neck malignancies, especially 
the upper aerodigestive epidermoid carcinoma (UADEC), 
generally progresses with locoregional recurrence.
Locoregional recurrences are the most frequent 
cause of failure in the initial treatment of epidermoid car-
cinoma patients, particularly in advanced cases in which 
the diagnosis was made late.2
Local recurrence is common, occurring in 40% to 
50% of patients treated initially with intentionally curati-
ve surgery, especially in advanced clinical stages of the 
disease.3 Such recurrences may be due to failure in the 
initial planning of therapy, to advanced clinical stages 
upon presentation, to the degree of molecular phenotype 
involvement, or to more aggressive tumor behavior. Most 
of these cases occur within the first 24 months of post-
therapy follow-up.
Regional recurrences are treated more successfully 
due to a surgical salvage paradigm in clinically negative 
necks upon the initial presentation, and that were not 
subjected to elective neck dissection. It is a consensus that 
the success rate of salvage surgery of the neck after prior 
neck dissection is poor.4-7
Salvage surgery, even in potential cases for this 
form of treatment, is controversial; most patients have a 
second recurrence or persistence of the disease within 
six months of salvage therapy.8 Physicians should take 
into account the morbidity, and mainly an unfavorable 
prognosis, when choosing the ideal treatment. In certain 
situations, the ideal treatment may be palliative support, 
even if the are potentially respectable lesions.
The clinical presentation of locoregional recurrence 
depends on the site of the primary tumor; indices vary 
from 25% to 48%. Gilbert and Kagan2 reviewed a number 
of series and showed that tonsillary and soft palate tumors 
tend to recur locally in a 2:1 frequency ratio compared 
with regional recurrences. The most frequent recurrence 
site for base of the tongue tumors is the endolarynx, by 
posterior extension of the tumor. Posterior wall tumors 
tend to recur locally after surgical treatment, in a 1:3 ratio 
compared with regional recurrences.
Evidence of single distance metastases is sparse. 
This may be an argument in favor of more aggressive 
“radical” therapy, namely major resection and reconstruc-
tion if there is local recurrence. Procedures include total 
glossolaryngectomy and pectoralis major muscle myocu-
taneous flap reconstruction. Regardless of the extension 
of surgery for the treatment of recurrences, the literature 
shows that the result of salvage procedures depends on 
the size of the initial tumor and the time for diagnosing 
recurrences. In other words, whether tumors were in 
initial clinical stages (I and II) and whether recurrences 
were detected one year following therapy. Selected cases 
of advanced tumors (clinical stages III and IV) upon the 
initial presentation, with early recurrences, may benefit 
from a second surgical procedure; these patients may 
progress favorably.9-10
Other treatment modalities in locoregional recur-
rences are radiotherapy alone or with chemotherapy. It 
is reserved for non-resectable tumors and/or in patients 
unable to undergo surgery. Radiotherapy salvage depends 
on technical limitations concerning prior irradiation doses 
and the toxicity of chemotherapy, such as kidney failure 
and medullary suppression.11
Many medical variables thus influence decision-
making in the locoregional recurrence of head and neck 
epidermoid carcinoma. These include the patient’s age, 
his or her performance status, initial clinical staging and 
staging of locoregional recurrences, and the type of tre-
atment.
The purpose of this paper was to make a descriptive 
analysis of demographic, clinical staging and progression 
data on locoregional recurrences of oropharyngeal tumors 
undergoing salvage surgery.
SERIES AND METHODS
A retrospective study of 78 patients with histo-
pathologically demonstrable oropharyngeal epidermoid 
carcinoma, treated initially by surgery with or with no 
postoperative radiotherapy, was carried out.
We defined locoregional recurrence in the oropha-
rynx as tumors diagnosed no later than 24 months after 
treatment. A tumor arising in the same anatomical site 
25 months or more after treatment was considered as a 
second tumor.
Demography (age, sex and racial group) and clinical 
staging data (tumor size and neck lymph nodes) were as-
sessed upon admission of patients and when the diagnosis 
of locoregional recurrence was made. These findings, as 
well as the progression after therapy, were evaluated in 
patients with locoregional recurrences that underwent 
salvage surgery. The type of locoregional recurrence was 
also defined as exclusively local, exclusively regional, or 
locoregional; the distribution of salvage surgery according 
to the type of recurrence and the procedure done as a 
result was also noted.
The Research Ethics Committee of the Heliopolis 
Hospital approved this study (number 497) on 10 October 
de 2006.
RESULTS
The mean follow-up time in our sample was 29.6 
months. The mean time for diagnosing locoregional recur-
rences as of the initial treatment was 9.2 months; three ca-
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ses were diagnosed more than 24 months after surgery.
In 78 patients, manifestations of a “new tumor” 
were as follows: 21 patients (27%) with local recurrences; 
5 patients (6.4%) with regional recurrences; 8 patients 
(10.2%) with locoregional recurrences; 1 patient (1.3%) 
with local recurrences and distance metastases on sepa-
rate dates; 2 patients (2.6%) with regional recurrences and 
distance metastases, which in one case were diagnosed in 
separate dates; 1 patient (1.3%) with regional recurrence 
and a second tumor in separate dates; 1 patient (1.3%) 
with a distance metastasis; and 7 patients (9%) with a 
second primary tumor. Absolute numbers for the “new 
tumor” manifestation type were: 38 patients (48.7%) with 
locoregional recurrences; 4 patients (5.1%) with distance 
metastases; and 9 patients (11.5%) with second tumors. Of 
38 local and regional recurrences, local recurrences were 
found in 22 patients (58%), regional recurrences were 
found in 8 patients (21%), and locoregional recurrences 
were found in 8 patients (21%) (Table 1).
tient (7.7%) was T2. Two (50%) of four patients undergoing 
salvage neck dissection were staged as N2b, and the other 
two (50%) were staged as N2c.
Clinical staging upon admission, before the initial 
treatment, of patients undergoing salvage surgery revealed 
that four patients (23.5%) were T1, seven patients (41.1%) 
were T2, five patients (29.5%) were T3, and one patient 
(5.9) was T4. Positive lymph nodes (N) were found as 
follows: 10 patients (58.8%) were N0, three patients (17.6%) 
were N1, one patient (5.9%) was N2a, one patient (5.9%) 
was N2b, and two patients (11.7%) were N2c.
Table 2 shows the results of salvage surgery types 
for the primary tumor and the neck.
Table 1. Distribution of the type of locoregional recurrence.
Variable    Category    n %
Recurrence    Local 22 58
 Regional 8 21
 Loco-regional 8 21
n= 38 patients.
Table 2. Distribution of salvage surgery according to the primary 
tumor and the neck
Variable Category n %
Primary tumor
Tumor resection by a natural 
access route
10 77,0
Partial glossectomy 2 15,3
*Neck    Buccopharyngectomy 1 7,7
RND/MRND 4 67,0
PND    2 33,0
*RND/MRND - radical / modified radical neck dissection. PND - pos-
terior neck dissection.
Thirty-seven patients presented locoregional re-
currences (a case in which a simultaneous diagnosis was 
made of a regional recurrence and a distance metastasis), 
of which 17 patients (45.9%) underwent salvage surgery 
and five patients were also treated with postoperative ra-
diotherapy. Recurrence in 13 (76.5%) of these 17 patients 
was on the primary tumor site; recurrence in 4 (23.5%) of 
these 17 patients had neck recurrences. No patient with any 
locoregional recurrences underwent salvage surgery.
Thirteen (59%) of 22 patients with single local 
recurrences underwent salvage surgery; four (57.1%) of 
seven patients with single regional recurrences underwent 
salvage neck dissection.
There were 16 male patients (94.1%) and one female 
patient (5.9%) that underwent salvage surgery. Twelve 
patients (70.58%) were white, 4 patients (23.52%) were of 
mixed skin color and 1 patient (5.9%) was black. The age 
when a diagnosis of locoregional recurrence was made 
ranged from 24 to 69 years (mean 52.8 years). There was 
one patient (5.9%) aged between 21 and 40 years, 11 
patients (64.7%) aged between 41 and 60 years, and 5 
patients (29.4%) aged over 61 years.
Clinical staging in locoregional recurrence showed 
that 12 (92.3%) of 13 patients undergoing salvage surgery 
of the primary tumor were staged as T1 and only one pa-
A second recurrence was seen in 11 (64.7) of 
17 patients; of these, six patients (54.5%) underwent a 
second salvage procedure, three patients (50%) due to 
local recurrences and three patients (50%) due to regional 
recurrences.
Only three (8.2%) of the remaining patients with 
locoregional recurrences underwent salvage radiotherapy. 
The other 17 patients (45.9%) were treated with palliative 
support measures.
The distance metastases sites were the subcutaneous 
neck tissues in three patients (75%) and the base of the 
cranium in one patient (25%). Locoregional disease control 
was achieved in three (75%) of these four patients.
A second oropharyngeal tumor was seen in three 
patients (33.4%); the soft palate was involved in two of 
these patients (66.7%) and the tonsillary region was invol-
ved in one patient (33.3%). There were six second tumor 
patients, as follows: one (11.1%) in the hard palate; one 
(11.1%) in the nasal fossa; one (11.1%) in the stomach; 
one (11.1%) is the distal esophagus; and two (22.2%) in 
the lungs. There were four 4 (44.4%) second tumors in the 
head and neck; three patients (75%) were treated surgically 
and one patient (25%) was treated with radiotherapy only. 
There were three cases of second primary tumors in the 
oropharynx, one of which had locoregional recurrence 
and was treated by salvage surgery.
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The progression of the 17 patients (45.9%) that 
underwent salvage surgery until the last follow-up visit in 
the study was as follows: 10 patients (58.8%) were alive 
and disease-free after a minimum 13-month follow-up; 6 
patients (35.3%) died due to locoregional disease; and one 
patient was alive but with regional disease and distance 
metastases.
DISCUSSION
When diagnosing a locoregional recurrence that is 
resectable, therapy is not necessarily surgical. Other factors 
have to be taken into account before salvage surgery, such 
as what was the initial treatment and what is the extension 
of recurrence. Surgery certainly is the treatment of choice 
in cases of an early stage (I and II) locoregional recurrence, 
regardless of the first treatment. Detection of resectable 
lesions at advanced stages often means that reconstruction 
is necessary. In this situation, quality of life issues after 
salvage surgery should be taken into account, since there 
may be postoperative complications due to fibrosis from 
previous procedures or from radiotherapy, meaning that 
there is less control of the disease. Our results are similar 
to those found in the literature; salvage surgery was done 
in all early stage (I and II) local recurrences, regardless of 
the extension of resection in the initial treatment. Salvage 
surgery was also done in all cases of locoregional recur-
rences at early clinical stages.6,12,13
One should bear in mind that after three years of 
follow-up, the probability of a second tumor developing 
is greater than the possibility of local recurrence. A second 
tumor may develop on the site of a primary tumor that was 
removed surgically. It is thus difficult to establish whether a 
new tumor that develops on the healing site of a previously 
removed tumor is the result of field cancerization or the 
presence of residual disease cell niches.14 Although it may 
be difficult to define whether it is a local recurrence or a 
second tumor on the healing site of a previously removed 
cancer, salvage surgery of a second tumor diagnosed more 
than 24 months after an original lesion was removed has a 
better prognosis, implying in different results of therapy in 
these cases. There were three cases initially diagnosed as 
“new tumors,” of which two were eventually considered 
locoregional recurrences; these were not candidates for 
salvage surgery. The third case was defined as a second 
primary oropharyngeal tumor, and the patient underwent 
surgery and locoregional control of the disease within a 
63.6-month follow-up period.
The rate of cervical cancer control following salvage 
surgery is higher in regional recurrence when palpable 
lymph nodes were absent upon the initial presentation or 
in patients not undergoing elective neck dissection. Our 
results are in line with these findings, given that patients 
undergoing salvage neck dissection had not been consi-
dered for neck dissection during the initial presentation. A 
further possibility is that such regional recurrences occur-
red out of previously manipulated areas, which suggests 
an increased success rate of salvage procedures.
An indication for contralateral neck dissection obeys 
the same oncological principles as those used when deci-
ding for neck dissection ipsilateral to the primary tumor. 
The importance of indicating contralateral neck dissection 
in the initial presentation of this disease is based on contra-
lateral regional recurrence rates. Kowalski et al.15 analyzed 
bilateral neck dissections in epidermoid carcinomas cases 
and showed that neck dissection should be done routi-
nely in patients at a high risk of developing contralateral 
metastases. This author’s follow-up revealed that 50% of 
patients with contralateral regional recurrences were not 
candidates for salvage surgery. Our study showed similar 
results, as only 50% of regional recurrences fulfilled the 
criteria for salvage neck dissection.
Amar et al.16 demonstrated statistically significant 
results in a study of contralateral cervical recurrence in 
epidermoid carcinomas of the mouth and larynx, showing 
that contralateral recurrence is related to the site and size 
of the primary tumor and the presence and number of 
ipsilateral lymph node involvement. This paper, however, 
found no relation between contralateral regional recur-
rence and the site of the primary tumor or lymph node 
involvement ipsilateral to the primary tumor.
Distance metastases are rare in oropharyngeal 
epidermoid carcinomas. A study of 1,244 head and neck 
epidermoid carcinoma patients revealed that 5% of the 
distance metastases presented with locoregional control of 
the disease. The diagnosis of distance metastases in 75% 
of our cases was made with locoregional control of the 
disease. Distance metastases developed concomitantly with 
local recurrence in only in only 25% of cases.17 Yonemoto 
et al.18 demonstrated that distance metastases developed 
in parallel with local recurrences. A diagnosis of distance 
metastases in the present study was made in 5.1% of cases 
during the follow-up period; one case (25%) was diagno-
sed upon locoregional control of the disease.
CONCLUSION
Patients diagnosed with epidermoid carcinoma of 
the oropharynx and with locoregional recurrence, which 
underwent salvage surgery in this study, initially had pre-
dominantly early clinical staging (I and II); locoregional 
disease control was achieved in 58.8% of cases at a mini-
mum 12 months after salvage.
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